Evidence map›Paper›PMID 14681830›Full record

ArticleAmerican journal of human genetics2004

Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family.

Hui Zhao, Ronghua Li, Qiuju Wang, Qingfeng Yan, Jian-Hong Deng, Dongyi Han, Yidong Bai, Wie-Yen Young, Min-Xin Guan

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 422 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. M.827A>G Variant in MT-RNR1 and Its Association With Hearing Loss: A Study in the Taiwanese Adult Population.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Gene Screening for Non-Syndromic Deafness in Hainanese Patients.The journal of international advanced otology · 2023
    Article
  19. Article
  20. Review

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Hui ZhaoDivision and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
Ronghua Li
Qiuju Wang
Qingfeng Yan
Jian-Hong Deng
Dongyi Han
Yidong Bai
Wie-Yen Young
Min-Xin Guan
Chinese People's Liberation Army · CNCincinnati Children's Hospital Medical Center · USThe University of Texas Health Science Center at San Antonio · USChinese General Hospital College of Nursing and Liberal Arts · PH

Funding

Molecular Mechanism of Aminoglycoside OtotoxicityR01DC005230 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI GUAN, MIN-XIN · 2002 to 2006
$1.8M
Genetic Correction of Maternally Inherited DiseasesR01NS044015 · NINDS · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI GUAN, MIN-XIN · 2002 to 2004
$525k
Biochemical Basis of Maternally Inherited DeafnessR03DC004958 · NIDCD · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI GUAN, MIN-XIN · 2001 to 2003
$222k
NIDCD NIH HHS DC04958NIDCD NIH HHS DC05230NIDCD NIH HHS R01 DC005230NIDCD NIH HHS R03 DC004958NINDS NIH HHS NS44015NINDS NIH HHS R01 NS044015
6 · The paper itself

Abstract

We report here the characterization of a large Chinese family with maternally transmitted aminoglycoside-induced and nonsyndromic deafness. In the absence of aminoglycosides, some matrilineal relatives in this family exhibited late-onset/progressive deafness, with a wide range of severity and age at onset. Notably, the average age at onset of deafness has changed from 55 years (generation II) to 10 years (generation IV). Clinical data reveal that the administration of aminoglycosides can induce or worsen deafness in matrilineal relatives. The age at the time of drug administration appears to be correlated with the severity of hearing loss experienced by affected individuals. Sequence analysis of mitochondrial DNA in this pedigree identified a homoplasmic C-to-T transition at position 1494 (C1494T) in the 12S rRNA gene. The C1494T mutation is expected to form a novel U1494-1555A base pair, which is in the same position as the C1494-1555G pair created by the deafness-associated A1555G mutation, at the highly conserved A site of 12S rRNA. Exposure to a high concentration of paromomycin or neomycin caused a variable but significant average increase in doubling time in lymphoblastoid cell lines derived from four symptomatic and two asymptomatic individuals in this family carrying the C1494T mutation when compared to four control cell lines. Furthermore, a significant decrease in the rate of total oxygen consumption was observed in the mutant cell lines. Thus, our data strongly support the idea that the A site of mitochondrial 12S rRNA is the primary target for aminoglycoside-induced deafness. These results also strongly suggest that the nuclear background plays a role in the aminoglycoside ototoxicity and in the development of the deafness phenotype associated with the C1494T mutation in the mitochondrial 12S rRNA gene.

Indexed as

AdultAgedAged, 80 and overAminoglycosidesAsian PeopleBase SequenceDeafnessDNA, MitochondrialDNA, RibosomalFemaleHumansInfantMaleMiddle AgedMutation, MissensePedigreeAminoglycosidesDNA, MitochondrialDNA, RibosomalRNA, Ribosomal, 16S

Identifiers

PMID14681830
PMCPMC1181901
OpenAlexW2043190075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.